Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Intangibles (2023 - 2024)

Rhythm Pharmaceuticals (RYTM) has disclosed Change in Intangibles for 2 consecutive years, with $500000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Change in Intangibles rose 83.82% to $500000.0 in Q3 2024 year-over-year; TTM through Dec 2025 was $500000.0, a 98.77% decrease, with the full-year FY2025 number at $40.0 million, down 1.23% from a year prior.
  • Change in Intangibles was $500000.0 for Q3 2024 at Rhythm Pharmaceuticals, down from $40.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $40.0 million in Q1 2024 to a low of $272000.0 in Q3 2023.